News Releases

January 23, 2018
Synlogic Announces Proposed Public Offering of Common Stock
January 5, 2018
Synlogic Progresses Clinical and Preclinical Pipeline and Outlines 2018 Catalysts
December 8, 2017
Synlogic and Ginkgo Bioworks Announce Collaboration as First Step Toward Building an Unprecedented Discovery Engine for Novel Living Medicines in Neurological and Liver Disorders
November 13, 2017
Synlogic Reports Third Quarter 2017 Financial Results and Recent Progress
November 8, 2017
Synlogic to Present at Upcoming Investor Conferences in November
November 8, 2017
Synlogic Reports Positive Top-Line Phase 1 Data Demonstrating Safety and Tolerability and Proof of Mechanism in Healthy Volunteers for SYNB1020, a Synthetic BioticTM Medicine for the Treatment of Hyperammonemia
October 24, 2017
Synlogic Receives Orphan Drug Designation for SYNB1618, a Synthetic BioticTM Medicine for the Treatment of Phenylketonuria
October 10, 2017
Synlogic Strengthens Leadership Team with Appointment of Chief Operating Officer and Chief Human Resources Officer
September 20, 2017
Synlogic to Webcast Presentation at the LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology
September 7, 2017
Synlogic Presents New Preclinical Data at International Congress of Inborn Errors of Metabolism
September 1, 2017
Synlogic to Webcast Presentation at BioCentury’s 24th Annual NewsMakers in the Biotech Industry Conference
August 28, 2017
Synlogic Completes Merger with Mirna Therapeutics
Displaying 181 - 192 of 213